The effects of reference pricing and other drug pricing policies

Morten Aaserud, Astrid A. Dahlgren, Jan Peter Kosters, Heidrun Strum, Craig R Ramsay, Andrew D. Oxman

Research output: Contribution to journalArticle

Abstract

We carried out a systematic review on studies of effects of pharmaceutical pricing policies. Ten studies of reference pricing and one study of index pricing were included. Based on the evidence in this review, mostly from senior citizens in British Columbia, Canada, reference drug pricing can reduce third party drug expenditures by inducing a shift in drug use towards less expensive drugs. We found no evidence of adverse effects on health and no clear evidence of increased health care utilisation.
Original languageEnglish
Pages (from-to)2-8
Number of pages7
JournalRegulatory Rapporteur
Volume3
Issue number10
Publication statusPublished - Oct 2006

    Fingerprint

Keywords

  • pharmaceutical policies
  • drug pricing
  • reference pricing

Cite this